Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Unknown 7Withdrawn 6Active not recruiting 3Terminated 2Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 9Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Leukemia, Myeloid, Acute 4Immunoblastic Lymphadenopathy 4Hematologic Neoplasms 4Lymphoma, T-Cell, Peripheral 3Lymphoma, Follicular 3Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Hodgkin Disease 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Spondylolisthesis 1Spinal Stenosis 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1

Interventions

Specimen Handling 1CVnCoV COVID-19 vaccine 1COH04S1 COVID-19 vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × COVID-19 × Lymphoid × Clear all
NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 2 Suspended
80 enrolled
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡